These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3965042)

  • 1. Low plasma dopamine-beta-hydroxylase in demented schizophrenics.
    Markianos M; Tripodianakis J
    Biol Psychiatry; 1985 Jan; 20(1):98-101. PubMed ID: 3965042
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
    Markianos M; Tripodianakis J; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
    Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
    Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
    [No Abstract]   [Full Text] [Related]  

  • 5. A biochemical study of tardive dyskinesia in young male patients.
    Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ
    Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
    DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
    Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
    Wagner RL; Jeste DV; Phelps BH; Wyatt RD
    J Clin Psychopharmacol; 1982 Oct; 2(5):312-4. PubMed ID: 7130432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral catecholamine enzyme function and cognitive impairment of elderly schizophrenics and controls.
    Bridge TP; Phelps BH; Cutler NR; Jeste DV; Wyatt RJ
    J Am Geriatr Soc; 1984 Apr; 32(4):259-64. PubMed ID: 6707406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum dopamine-beta-hydroxylase in schizophrenic patients.
    Fujita K; Ito T; Maruta K; Teradaira R; Beppu H; Nakagami Y; Kato Y; Nagatsu T; Kato T
    J Neurochem; 1978 Jun; 30(6):1569-72. PubMed ID: 670998
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia.
    Castellani S; Ziegler MG; van Kammen DP; Alexander PE; Siris SG; Lake CR
    Arch Gen Psychiatry; 1982 Oct; 39(10):1145-9. PubMed ID: 7125844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
    Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
    Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme studies in tardive dyskinesia. II. Familial aspects.
    Delisi LE; Jeste DV; Phelps BH; Wyatt RJ
    J Clin Psychopharmacol; 1982 Oct; 2(5):315-7. PubMed ID: 7130433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients.
    Wyatt RJ; Schwartz MA; Erdelyi E; Barchas JD
    Science; 1975 Jan; 187(4174):368-70. PubMed ID: 1111112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma dopamine beta-hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia.
    Ross SB; Böök JA; Wetterberg L
    Clin Genet; 1981 May; 19(5):415-7. PubMed ID: 7296932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia.
    Jeste DV; Phelps B; Wagner RL; Wise CD; Wyatt RJ
    Lancet; 1979 Oct; 2(8147):850-1. PubMed ID: 90943
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of MAO, D beta H, and COMT activities in chronic schizophrenics selected on the basis of nailfold capillary pattern.
    Dunlop SR; Sattin A; Shea P; Hendrie HC
    Acta Psychiatr Scand; 1981 Nov; 64(5):409-14. PubMed ID: 7347105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.